Cawachi Limited

2664.T
Pharmaceutical Retailers
2026/08/21 Updated
Market Cap: $533.8M (¥84.9B)
Stock Price: $23.90 (¥3,800)
Exchange Rate: 1 USD = ¥158.98

Notice Regarding Implementation of Interim Dividend and Dividend Forecast

Kawachi Pharmaceutical Co., Ltd. announced the implementation of an interim dividend beginning in the fiscal year ending March 2027, raising the annual dividend to 100 yen per share (an increase of 20 yen compared to the previous year).

Importance:
Page Updated: April 28, 2026
IR Disclosure Date: April 28, 2026

Key Figures

  • Interim Dividend Record Date: September 15 each year
  • Regular Dividend Forecast for Fiscal Year Ending March 2027: 100 yen 00 sen (20 yen increase compared to previous year)
  • Interim Dividend Forecast for Fiscal Year Ending March 2027: 50 yen 00 sen

AI要約

Overview of Implementation of Interim Dividend and Dividend Forecast

Kawachi Pharmaceutical Co., Ltd. has resolved to implement an interim dividend starting from the fiscal year ending March 2027 and to change the dividend from the current once-a-year year-end dividend to twice a year (interim and year-end). This aims to enhance opportunities for returning profits to shareholders. The record date for the interim dividend is set as September 15 each year. The dividend forecast for the fiscal year ending March 2027 anticipates a regular dividend of 100 yen per share, representing a 20 yen increase from the previous year. An interim dividend of 50 yen and a year-end dividend of 50 yen are planned.

Impact on Shareholders and Future Plans

The interim dividend will target shareholders listed or recorded in the shareholder registry as of September 15, 2026. The payment start date and dividend amount for the interim dividend will be formally resolved at the interim financial results board meeting. Additionally, the year-end dividend for the fiscal year ending March 2026 will be proposed at the 59th Annual General Meeting of Shareholders scheduled for June 2026. This change in the dividend system is expected to increase the timing of profit returns to shareholders and contribute to enhancing the stock value.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Kawachi Pharmaceutical Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →